In September 2024, Androlabs held a Scientific Advisory Committee (SAC) meeting in London, bringing together 17 of Europe's most prominent key opinion leaders in men's health and endocrinology to the Royal Society of Medicine. The SAC meeting provided a dynamic forum for open discussion and knowledge sharing, with a focus on testosterone therapy and its effects on men's health.
The meeting included in-depth discussions about key topics such as testosterone's cardiovascular safety, managing haematocrit responses to therapy, and understanding the efficacy of testosterone gels. Attendees agreed on several key points, including improved testosterone management education for healthcare providers. This discussion highlighted the importance of personalised care in testosterone therapy, as well as improving patient compliance during the first few months of treatment.
A significant outcome of the meeting was the agreement to create a position statement on testosterone's cardiovascular safety, which will be led by Prof. Michael Zitzmann. This initiative will help reduce hesitancy around testosterone replacement therapy. The meeting also set the stage for future research, particularly in the areas of testosterone’s impact on type 2 diabetes and long-term patient outcomes. Androlabs will continue to drive these conversations, ensuring they influence real-world clinical practice and enhance men’s health globally.
At last month's meeting, we had the pleasure of hosting illustrator Thomas McLean who captured his perspective of the key insights from the day's sessions through his insightful illustrations.
